114 related articles for article (PubMed ID: 16817353)
1. [22q11.2 deletion syndrome].
Ishikawa T
Nihon Rinsho; 2006 Jun; Suppl 2():70-3. PubMed ID: 16817353
[No Abstract] [Full Text] [Related]
2. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.
Prasad SE; Howley S; Murphy KC
Dev Disabil Res Rev; 2008; 14(1):26-34. PubMed ID: 18636634
[TBL] [Abstract][Full Text] [Related]
3. Patient with a 22q11.2 deletion with no overlap of the minimal DiGeorge syndrome critical region (MDGCR).
McQuade L; Christodoulou J; Budarf M; Sachdev R; Wilson M; Emanuel B; Colley A
Am J Med Genet; 1999 Sep; 86(1):27-33. PubMed ID: 10440825
[TBL] [Abstract][Full Text] [Related]
4. Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial Syndrome.
Sullivan KE
Immunol Allergy Clin North Am; 2008 May; 28(2):353-66. PubMed ID: 18424337
[TBL] [Abstract][Full Text] [Related]
5. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome.
Raux G; Bumsel E; Hecketsweiler B; van Amelsvoort T; Zinkstok J; Manouvrier-Hanu S; Fantini C; Brévière GM; Di Rosa G; Pustorino G; Vogels A; Swillen A; Legallic S; Bou J; Opolczynski G; Drouin-Garraud V; Lemarchand M; Philip N; Gérard-Desplanches A; Carlier M; Philippe A; Nolen MC; Heron D; Sarda P; Lacombe D; Coizet C; Alembik Y; Layet V; Afenjar A; Hannequin D; Demily C; Petit M; Thibaut F; Frebourg T; Campion D
Hum Mol Genet; 2007 Jan; 16(1):83-91. PubMed ID: 17135275
[TBL] [Abstract][Full Text] [Related]
6. Deconstructing DiGeorge syndrome.
Schinke M; Izumo S
Nat Genet; 2001 Mar; 27(3):238-40. PubMed ID: 11242098
[No Abstract] [Full Text] [Related]
7. [DiGeorge syndrome].
Hamada H; Terai M
Nihon Rinsho; 2006 Jun; Suppl 2():46-8. PubMed ID: 16817347
[No Abstract] [Full Text] [Related]
8. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome.
Gothelf D; Eliez S; Thompson T; Hinard C; Penniman L; Feinstein C; Kwon H; Jin S; Jo B; Antonarakis SE; Morris MA; Reiss AL
Nat Neurosci; 2005 Nov; 8(11):1500-2. PubMed ID: 16234808
[TBL] [Abstract][Full Text] [Related]
9. Cognitive correlates of a functional COMT polymorphism in children with 22q11.2 deletion syndrome.
Shashi V; Keshavan MS; Howard TD; Berry MN; Basehore MJ; Lewandowski E; Kwapil TR
Clin Genet; 2006 Mar; 69(3):234-8. PubMed ID: 16542388
[TBL] [Abstract][Full Text] [Related]
10. Association between autism spectrum disorder in individuals with velocardiofacial (22q11.2 deletion) syndrome and PRODH and COMT genotypes.
Radoeva PD; Coman IL; Salazar CA; Gentile KL; Higgins AM; Middleton FA; Antshel KM; Fremont W; Shprintzen RJ; Morrow BE; Kates WR
Psychiatr Genet; 2014 Dec; 24(6):269-72. PubMed ID: 25325218
[TBL] [Abstract][Full Text] [Related]
11. Introduction: advances in research on velo-cardio-facial syndrome/22q11.2 deletion syndrome.
Kates WR; Emanuel BS
Dev Disabil Res Rev; 2008; 14(1):1-2. PubMed ID: 18636630
[No Abstract] [Full Text] [Related]
12. [Transient neonatal hypocalcemia. Onset Manifestation of the 22q11.2 deletion syndrome].
Pusceddu M; Bertone A; Campra D; Pontoriero D; Guala A
Minerva Pediatr; 2002 Aug; 54(4):343-5. PubMed ID: 12131871
[No Abstract] [Full Text] [Related]
13. Velo-cardio-facial syndrome.
Shprintzen RJ; Higgins AM; Antshel K; Fremont W; Roizen N; Kates W
Curr Opin Pediatr; 2005 Dec; 17(6):725-30. PubMed ID: 16282778
[TBL] [Abstract][Full Text] [Related]
14. Effects of COMT genotype on behavioral symptomatology in the 22q11.2 Deletion Syndrome.
Bearden CE; Jawad AF; Lynch DR; Monterossso JR; Sokol S; McDonald-McGinn DM; Saitta SC; Harris SE; Moss E; Wang PP; Zackai E; Emanuel BS; Simon TJ
Child Neuropsychol; 2005 Feb; 11(1):109-17. PubMed ID: 15846854
[TBL] [Abstract][Full Text] [Related]
15. The phenotypic spectrum of the 10p deletion syndrome versus the classical DiGeorge syndrome.
Van Esch H; Groenen P; Fryns JP; Van de Ven W; Devriendt K
Genet Couns; 1999; 10(1):59-65. PubMed ID: 10191430
[TBL] [Abstract][Full Text] [Related]
16. Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome.
Gothelf D; Schaer M; Eliez S
Dev Disabil Res Rev; 2008; 14(1):59-68. PubMed ID: 18636637
[TBL] [Abstract][Full Text] [Related]
17. Does dysregulation of catechol-O-methyltransferase predispose to opioid-induced hallucinations? A report of a patient with microdeletion of chromosome 22 and opioid-associated hallucinations.
Gitlin MC; Taylor BK; Kalarickal PL; Lonseth ED
Pain Med; 2007; 8(1):84-6. PubMed ID: 17244108
[TBL] [Abstract][Full Text] [Related]
18. 22q11.2 deletion syndrome and schizophrenia.
Qin X; Chen J; Zhou T
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1181-1190. PubMed ID: 33098288
[TBL] [Abstract][Full Text] [Related]
19. Mutations in TBX1 genocopy the 22q11.2 deletion and duplication syndromes: a new susceptibility factor for mental retardation.
Torres-Juan L; Rosell J; Morla M; Vidal-Pou C; García-Algas F; de la Fuente MA; Juan M; Tubau A; Bachiller D; Bernues M; Perez-Granero A; Govea N; Busquets X; Heine-Suñer D
Eur J Hum Genet; 2007 Jun; 15(6):658-63. PubMed ID: 17377518
[TBL] [Abstract][Full Text] [Related]
20. Hyperprolinemia as a clue in the diagnosis of a patient with psychiatric manifestations.
Duarte M; Afonso J; Moreira A; Antunes D; Ferreira C; Correia H; Marques M; Sequeira S
Brain Dev; 2017 Jun; 39(6):539-541. PubMed ID: 28202261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
